• Pharma companies set for strong performance in March 2025 quarter amid earning weakness

    Source: Buzz FX / 24 Apr 2025 03:30:24   America/Chicago


    Life Sciences- 2 min read
    Pharma companies set for strong performance in March 2025 quarter amid earning weakness
    Sun Pharma is expected to post a 9% year-on-year revenue growth, supported by its US specialty portfolio and steady growth in
    Read more...
Share on,